Brief: Mira Pharmaceuticals Inc - FDA Clears Mira's Ind For Ketamir-2 - SEC Filing
28/07/2025 22:03
Mira Pharmaceuticals Inc MIRA.O: MIRA PHARMACEUTICALS INC - FDA CLEARS MIRA'S IND FOR KETAMIR-2 - SEC FILING MIRA PHARMACEUTICALS INC - PRECLINICAL DATA SHOWS ANALGESIC EFFECTS AND SAFETY - SEC FILING MIRA PHARMACEUTICALS INC - KETAMIR-2 ACHIEVES GOOD BIOAVAILABILITY AND PENETRATION - SEC FILING MIRA PHARMACEUTICALS INC - PLANS PHASE 2A TRIAL IN U.S. Q4 2025 - SEC FILING Source text: [ID:n0001641172-25-021155] Further company coverage: MIRA.O
Recent news on Mira Pharmaceuticals
See all newsBrief: Mira Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
Brief: MIRA Pharmaceuticals Secures Worldwide Exclusive Rights To MIRA-55 And SKNY-1 - SEC Filing
Brief: Mira Pharmaceuticals Enters Into Amendment No 1 To Exclusive License Agreement With Miralogx
Brief: Mira Pharmaceuticals Inc - Completes Phase 1 Dosing Of Ketamir-2 - SEC Filing
Brief: Mira Pharmaceuticals Inc - Initiates Phase 1 Study Of Ketamir-2 - SEC Filing